The relative financial well-being of the healthcare industry is leading to a rebirth of mergers and acquisitions (M&A) activity, notably in the European medical imaging market, according to new analysis from Frost & Sullivan. Drug makers, research labs, equipment manufacturers and healthcare technology companies have been the active acquirers, whereas hospitals, insurers and pharmacological companies have made a limited number of acquisitions, notes the report.
According to Consolidation/M&A in Medical Imaging Market, the market earned revenues of $5,650.4 million in 2009. Tier I companies are often the major global participants with high revenues and a wide range of product offerings across all segments of medical imaging. Tier II companies have a notable presence in the medical imaging market in terms of revenues, and their product portfolio covers most segments of the medical imaging market. Lastly, tier III companies have relatively lesser product offerings and are focused on selected segments of the medical imaging market.
“The economic slump, availability of low-priced acquisitions, and ready financing for the healthcare industry have increased the viability of tier I companies to expand market share through acquisitions,” says Frost & Sullivan Research Analyst Beulah Devadason. “Acquisition focus has mainly been in emerging markets such as Brazil, Russia, India, and China. It is likely to continue going forward.”